Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis

Juvenile idiopathic arthritis (JIA) is often associated with chronic anterior uveitis. Presence of vision threatening complications may indicate immunosuppressive therapy. In this study, the experience with cyclosporine A (CsA) as mono- or combination-therapy is analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Uveitis Arthritis Arthritis, Juvenile Autoimmune Diseases Connective Tissue Diseases Eye Diseases Immune System Diseases Joint Diseases Juvenile Idiopathic Arthritis Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases Uveal Diseases

Age range

Up to 16 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Deutsches Zentrum für Kinder- und Jugendrheumatologie, Garmisch-Partenkirchen, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

uveitis
JIA

Treatment and study plan

Cyclosporine A

Drug

Sponsors and collaborators

Lead sponsor

St. Franziskus Hospital

Other

Registry information

Official study title

Efficacy and Adverse Effects of Cyclosporine A in the Treatment of Chronic Anterior Uveitis in Patients With Juvenile Idiopathic Arthritis

Important dates

Study start: 1991
Study completion: 2006
First posted: Nov 28, 2006
Registry last updated: Jun 3, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed